280 related articles for article (PubMed ID: 31734299)
1. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.
Cho S; Lee YJ; Ko YG; Kang TS; Lim SH; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2019 Dec; 12(23):2359-2370. PubMed ID: 31734299
[TBL] [Abstract][Full Text] [Related]
2. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
[TBL] [Abstract][Full Text] [Related]
3. Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions.
Kim TI; Chen JF; Orion KC
Vasc Med; 2019 Dec; 24(6):528-535. PubMed ID: 31686603
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dual-antiplatelet therapy durations after endovascular revascularization of infrainguinal arteries.
Sarode K; Mohammad A; Das S; Vinas A; Banerjee A; Tsai S; Armstrong EJ; Shammas NW; Klein A; Brilakis ES; Banerjee S
Ann Vasc Surg; 2015 Aug; 29(6):1235-44. PubMed ID: 26026491
[TBL] [Abstract][Full Text] [Related]
5. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.
Beiswenger AC; Jo A; Harth K; Kumins NH; Shishehbor MH; Kashyap VS
J Vasc Surg; 2018 Jun; 67(6):1922-1932.e6. PubMed ID: 29801560
[TBL] [Abstract][Full Text] [Related]
7. Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries.
Kronlage M; Wassmann M; Vogel B; Müller OJ; Blessing E; Katus H; Erbel C
Drug Des Devel Ther; 2017; 11():2937-2945. PubMed ID: 29062225
[TBL] [Abstract][Full Text] [Related]
8. Effects of dual antiplatelet therapy on graft patency after lower extremity bypass.
Belkin N; Stoecker JB; Jackson BM; Damrauer SM; Glaser J; Kalapatapu V; Golden MA; Wang GJ
J Vasc Surg; 2021 Mar; 73(3):930-939. PubMed ID: 32777321
[TBL] [Abstract][Full Text] [Related]
9. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
[TBL] [Abstract][Full Text] [Related]
10. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
[TBL] [Abstract][Full Text] [Related]
11. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.
Singh N; Ding L; Magee GA; Shavelle DM; Kashyap VS; Garg PK
Circ Cardiovasc Interv; 2020 Aug; 13(8):e008791. PubMed ID: 32791948
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
Qi J; Li Y; Li J; Jing Q; Xu K; Gao C; Ma L; Zhang Z; Xu B; Han Y
Catheter Cardiovasc Interv; 2017 Mar; 89(S1):555-564. PubMed ID: 28318138
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
[TBL] [Abstract][Full Text] [Related]
14. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.
Navarese EP; Wernly B; Lichtenauer M; Petrescu AM; Kołodziejczak M; Lauten A; Frediani L; Veulemanns V; Wanha W; Wojakowski W; Lesiak M; Ferrante G; Zeus T; Tantry U; Bliden K; Buffon A; Contegiacomo G; Jung C; Kubica J; Pestrichella V; Gurbel PA
Int J Cardiol; 2018 Oct; 269():292-297. PubMed ID: 30045826
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).
Wegerif ECJ; Ünlü Ç; Generaal MI; van den Bor RM; van de Ven PM; Bots ML; de Borst GJ
Am Heart J; 2024 Jul; 273():121-129. PubMed ID: 38608997
[TBL] [Abstract][Full Text] [Related]
16. Association of antiplatelet therapy with clinical outcomes in patients with peripheral artery disease.
Al-Sadawi M; Tao M; Dhaliwal S; Masson R; Bhagat AA; Parikh PB; Lawson WE; Reilly JP
Cardiovasc Revasc Med; 2024 May; 62():66-72. PubMed ID: 38176961
[TBL] [Abstract][Full Text] [Related]
17. Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
Qiu M; Li Y; Li J; Xu K; Jing Q; Dong S; Jin Z; Zhao P; Xu B; Han Y
Catheter Cardiovasc Interv; 2017 Mar; 89(S1):565-573. PubMed ID: 28211603
[TBL] [Abstract][Full Text] [Related]
18. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.
Kim TI; DeWan A; Murray M; Wang H; Mani A; Mena-Hurtado C; Guzman RJ; Ochoa Chaar CI
Ann Vasc Surg; 2024 Aug; 105():150-157. PubMed ID: 38593922
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
Ji Y; Wang B; Wu G; Zhang Y; Wang Q; Zhou M
Ther Adv Chronic Dis; 2023; 14():20406223231213262. PubMed ID: 38085917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
